cp wire

CP Wire Articles

Turning Point Therapeutics Updates Its IPO Filing – Will Raise Up to $152 Million

Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, updated its S-1 Filing. The company is proposing... read more

Mon, 04/8/19 - 09:40 am
NASH-focused medtech company DIAFIR appoints Mr. Richard Guillaume to its BOD
RENNES, FRANCE — DIAFIR, a medical technology company focused on the development, manufacture and sale of innovative diagnostic solutions... read more
Mon, 04/8/19 - 12:18 am
Microbiome Report for week ending 3/30/19

Enterome to Present Data on... read more

Sat, 04/6/19 - 02:25 pm
Celgene and Acceleron Submit BLA for Luspatercept

Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) announced on 4/5/19 that Celgene has submitted a Biologics License Application (BLA) for luspatercept, an erythroid... read more

Fri, 04/5/19 - 10:44 am
C3J Therapeutics Receives Patent Covering Synthetic Bacteriophage

C3J Therapeutics, Inc. (C3J) a private clinical stage biotechnology company focused on the development of novel targeted antimicrobials based on bacteriophage, today announced that the United... read more

Thu, 04/4/19 - 10:24 am

Pages